We are a renewable energy company specializing in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement to fossil fuels. We develop, own, and operate RNG projects, using proven technologies that supply renewable fuel into the transportation and electrical power sectors. Having participated in the industry […]

We intend to focus our efforts on completing a business combination with a high-quality software or technology-enabled growth business serving consumers or enterprises in the United States with an enterprise value between $500 million and $1.5 billion. (S-1 is dated Dec. 15, 2020.) We plan to leverage our extensive network in the venture capital and private equity industries as […]

We intend to focus on businesses primarily operating in the healthcare sector in the United States. (Note: MedTech Acquisition Corp. upsized its IPO to price 22 million units, up from 20 million, at $10 each to raise $220 million.)

We are an online and mobile commerce company and conduct our business through our online retail store on our Website – www.wnw108.com. We sell a myriad of food products on our Website. We do not grow, foster or manufacture any food products and all the food products sold on our Website are from our suppliers. We […]

We intend to invest in fast-growing technology companies. We are led by a team of proven venture capital investors. We seek to build upon the experience and successes of Corner Ventures, a venture capital firm affiliated with the management, and co-founder of its predecessor firm, DAG Ventures. John Cadeddu, our co-chairman and Marvin Tien, our co-chairman and CEO, serve as general partners and […]

We intend to focus on businesses that have their primary operations located in North America in the healthcare industry. Our focus will be on the orthopedic and spine industry in the United States and other developed countries.  (Note: Viveon Health Acquisition slightly upsized its IPO at pricing – to 17.5 million units, up from 17 million units […]

We are a clinical-stage biopharmaceutical company developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Our conditionally active biologics, or CABs, capitalize on our proprietary discoveries with respect to tumor biology, enabling us to target known and widely validated tumor antigens that have previously been difficult […]

We initially intend to focus our search on target businesses in the education, training, reskilling, human capital and education technology industries.

Our focus will be on target companies with enterprise values of about $1 billion to $4 billion. We intend to capitalize on our management team’s ability to identify, acquire and operate businesses across a broad range of sectors, that may provide opportunities for attractive long-term risk-adjusted returns. Our sponsor is affiliated with Riverside Management Group (RMG), […]

We intend to focus our search for a target business in the biotechnology and/or telemedicine sector of the healthcare industry in North America.